Editorial: Hepatic Lipase Genotype, Diabetes Risk, and Implications for Preventative Medicine

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 5, 2004, Pages 2015-2018

  Shuldiner, Alan R ^a,b   Hoppman, Nicole ^a   Pollin, Toni I ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Vet Admin Geriatrics Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HIGH DENSITY LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL LIPASE;

A ALLELE; ALLELE; DIABETIC OBESITY; DIAGNOSTIC VALUE; EDITORIAL; ENVIRONMENTAL FACTOR; EXERCISE; G ALLELE; GENE FUNCTION; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LIFESTYLE; LIPC GENE; MENOPAUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE TRAIT; RISK ASSESSMENT; WEIGHT REDUCTION; ENZYMOLOGY; GENETICS; INSULIN DEPENDENT DIABETES MELLITUS; LIVER; METHODOLOGY; NOTE; PREVENTIVE MEDICINE;

DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIPASE; LIVER; PREVENTIVE MEDICINE;

EID: 2442447051     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0521     Document Type: Editorial

References (20)

1. Lindström J, Eriksson JG, Valle TT, Aunola S, Cepaitis Z, Hakumaki M, Hämaläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Martikkala V, Moltchanov V, Rastas M, Salminen V, Sundvall J, Uusitupa M, Tuomilehto J 2003 Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial. J Am Soc Nephrol 14(7 Suppl 2):S108-S113
2. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group 2002 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403
3. Todorova B, Kubaszek A, Pihlajamäki J, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinä nen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M 2004 The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: The Finnish Diabetes Prevention Study. J Clin Endocrinol Metab 89:2019-2023
4. Nicklas BJ, van Rossum EF, Berman DM, Ryan AS, Dennis KE, Shuldiner AR 2001 Genetic variation in the peroxisome proliferator-activated receptor-γ2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 50:2172-2176
5. Wilund KR, Ferrell RE, Phares DA, Goldberg AP, Hagberg JM 2002 Changes in high-density lipoprotein-cholesterol subfractions with exercise training may be dependent on cholesteryl ester transfer protein (CETP) genotype. Metabolism 51:774-778
6. Halverstadt A, Phares DA, Ferrell RE, Wilund KR, Goldberg AP, Hagberg JM 2003 High-density lipoprotein-cholesterol, its subfractions, and responses to exercise training are dependent on endothelial lipase genotype. Metabolism 52:1505-1511
7. Deeb SS, Peng R 2000 The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity. J Lipid Res 41:155-158
8. Pihlajamaki J, Karjalainen L, Karhapaa P, Vanhkonen I, Taskinen MR, Deeb SS, Laakso M 2000 G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 20:1789-1795
9. Jansen H, Waterworth DM, Nicaud V, Ehnholm C, Talmud PJ 2001 Interaction of the common apolipoprotein C-III (APOC3-482C > T) and hepatic lipase (LIPC-514C > T) promoter variants affects glucose tolerance in young adults. European Atherosclerosis Research Study II (EARS-II). Ann Hum Genet 65(Pt 3):237-243
10. Jansen H, Verhoeven AJ, Weeks L, Kastelein JJ, Halley DJ, van den Ouweland A, Jukema JW, Seidell JC, Birkenhager JC 1997 Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol 17:2837-2842
11. Merikangas KR, Risch N 2003 Genomic priorities and public health. Science 302:599-601
12. Andrews LB, Fullerton JE, Holtzman NA, Motulsky AG 1994 Assessing genetic risks: implications for health and social policy. Washington, DC: National Academy Press
13. Touchette N, Holtzman NA, Davis JG, Feetham S 1997 Toward the 21st century: incorporating genetics into primary health care. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
14. Collins FS 1997 Preparing health professionals for the genetic revolution. JAMA 278:1285-1286
15. Emery J, Watson E, Rose P, Andermann A 1999 A systematic review of the literature exploring the role of primary care in genetic services. Fam Pract 16:426-445
16. Hayflick SJ, Eiff MP 1998 The role of primary care providers in the delivery of genetics services. Community Genet 1:18-22
17. Friedman JM, Blitzer M, Elsas LJ, Francke U, Willard HF 1998 Clinical objectives in medical genetics for undergraduate medical students. Association of Professors of Human Genetics, Clinical Objectives Task Force. Genet Med 1:54-55
18. Greendale K, Pyeritz RE 2001 Empowering primary care health professionals in medical genetics: how soon? How fast? How far? Am J Med Genet 106:223-232
19. Harvey-Berino J, Gold EC, West DS, Shuldiner AR, Walston J, Starling RD, Nolan A, Silver K, Poehlman ET 2001 Does genetic testing for obesity influence confidence in the ability to lose weight? A pilot investigation. J Am Diet Assoc 101:1351-1353
20. Botkin JR, Smith KR, Croyle RT, Baty BJ, Wylie JE, Dutson D, Chan A, Hamann HA, Lerman C, McDonald J, Venne V, Ward JH, Lyon E 2003 Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet 118A:201-209